Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
117
datasets available to search
ShareScore release 0.9.0
Dataset results
117 results for “Witness”
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients Wit
ClinicalTrials.gov study NCT03740893. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers Wit
ClinicalTrials.gov study NCT00871507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient Wit
ClinicalTrials.gov study NCT05249894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical and Magnetic Resonance Imaging Evaluation of Micro Fragmented Adipose Tissue Injection Combined With Bone Marrow Stem Cells on Healing of Temporomandibular Joint Internal Disc Derangement Wit
ClinicalTrials.gov study NCT05815771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat Wit
ClinicalTrials.gov study NCT03105349. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients Wit
ClinicalTrials.gov study NCT05459532. IPD Sharing: YES. Countries: 1. Publications: 0.
The OceanX 2025 campaign on the OceanXplorer research vessel for NASA in collaboration with OceanX to collect critical in-water optical measurements and concentrations of carbon, phytoplankton pigments and community composition across the western Indian O
The OceanX 2025 campaign on the OceanXplorer presented a unique and compelling opportunity for NASA in collaboration with OceanX to collect critical in-water optical measurements and concentrations of carbon, phytoplankton pigments and community composition in the Indian Ocean and eastern Atlantic Ocean. This timing coincides with the second year of NASA's PACE mission, providing an exceptional opportunity for satellite data product validation. The ocean and coastal areas that OceanXplorer navigated through spanned low to high productivity waters, yield many opportunities for clear skies (enabling coincident in situ measurements with satellite observations), and diverse water types (clear blue ocean to algal-rich coastal ocean to more turbid nearshore) makes this opportunity ideal for validating PACE data with crucial in-situ data to ensure the accuracy and reliability of PACE measurements. The primary aim for NASA GSFC/OEL/FSG and PVST participation on the OceanXplorer field campaign in 2025 was to collect a suite of state-of-the-art ocean measurements for the validation of NASA's PACE satellite mission data products. Field measurements included ocean optical properties of ocean radiometry, absorption, attenuation, scattering, as well as phytoplankton pigments, organic carbon, and phytoplankton community composition, biomass and physiology as well as aerosol measurements.
Schoen van zwart kalfs(?) leer met bandsluiting op wreef en sierstiksel van wit katoen op de voorvoet
<u>Source</u>: Europeana <br><u>4DCity URL</u>: <a href="https://4dcity.org/imgupload/1652523802.8704.jpg">https://4dcity.org/imgupload/1652523802.8704.jpg</a> <br><u>Original Image URL</u>: <a href="https://api.europeana.eu/thumbnail/v2/url.json?uri=https%3A%2F%2Flh4.ggpht.com%2FllZpcznv8zQTgZMf6qH0UZE9lHuPc_Kk4lqB_3UwSmuZPYUmmXorzTbczDKrqWfXgtWorQOdOgxTb8c6ELhpfT7UZjMz%3Ds0&type=IMAGE">https://api.europeana.eu/thumbnail/v2/url.json?uri=https%3A%2F%2Flh4.ggpht.com%2FllZpcznv8zQTgZMf6qH0UZE9lHuPc_Kk4lqB_3UwSmuZPYUmmXorzTbczDKrqWfXgtWorQOdOgxTb8c6ELhpfT7UZjMz%3Ds0&type=IMAGE</a> <br><br><u>Image-Metadata:</u><br>Filename: 1652523802.8704.jpg<br>Image Dimensions: 400x230<br>Megapixels: 0.09 MP<br>Filesize: 5.53 KB<br>
Vest van lichtblauw laken, met rugpand van wit katoen, onderdeel van ambtskostuum
<u>Source</u>: Europeana <br><u>4DCity URL</u>: <a href="https://4dcity.org/imgupload/1652523802.82.jpg">https://4dcity.org/imgupload/1652523802.82.jpg</a> <br><u>Original Image URL</u>: <a href="https://api.europeana.eu/thumbnail/v2/url.json?uri=https%3A%2F%2Flh3.googleusercontent.com%2F-JWC9O6vE34YIg9OtJaXHka29o2PgrmTmtLgKCgCnpwFKu7eg4sDI4LGOuLmXEdrqnFPldbeUJ3SeOrpcyiQBUCroA%3Ds0&type=IMAGE">https://api.europeana.eu/thumbnail/v2/url.json?uri=https%3A%2F%2Flh3.googleusercontent.com%2F-JWC9O6vE34YIg9OtJaXHka29o2PgrmTmtLgKCgCnpwFKu7eg4sDI4LGOuLmXEdrqnFPldbeUJ3SeOrpcyiQBUCroA%3Ds0&type=IMAGE</a> <br><br><u>Image-Metadata:</u><br>Filename: 1652523802.82.jpg<br>Image Dimensions: 400x496<br>Megapixels: 0.20 MP<br>Filesize: 9.91 KB<br>
Post Operative Pain Following Pulpectomy Versus Pulpotomy in Primary Molars Wit Irreversible Pulpitis
ClinicalTrials.gov study NCT06903013. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparison of Mesh Fixation Wit Cyanoacrylate vs Suture in Inguinal Hernia Surgery
ClinicalTrials.gov study NCT02197585. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients Wit
ClinicalTrials.gov study NCT04020653. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Effectiveness of Electrical Stimulation With Mime Therapy Versus Electrical Stimulation With Proprioceptive Neuromuscular Facilitation on Improving Facial Asymmetry and Quality of Life in Patients Wit
ClinicalTrials.gov study NCT07028138. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment Wit
ClinicalTrials.gov study NCT00216697. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Certificates and Witnesses for Multi-Objective Queries in Markov Decision Processes - Artefact
<div> <h1>Artefact for CAV 2024</h1> <a href="https://github.com/cxlvinchau/cav2024-experiments#artefact-for-cav-2024"></a></div> <p>This artefact accompanies the submission "Certificates and Witnesses for Multi-Objective Queries in Markov Decision Processes".</p> <div> <h2>Contents of this artefact</h2> <a href="https://github.com/cxlvinchau/cav2024-experiments#contents-of-this-artefact"></a></div> <p>This artefact consists of two different folders, namely <code>data</code> and <code>software</code>.</p> <div> <h3>The <code>data</code> folder</h3> <a href="https://github.com/cxlvinchau/cav2024-experiments#the-data-folder"></a></div> <p>The <code>data</code> folder contains data and results presented in the experimental section, along with models and properties that have been used. For every model and type of query (mean-payoff or reachability), there is a separate folder, containing the following types of files:</p> <ul> <li><code>data.csv</code> - A csv file where each row corresponds to a query and a model the query was considered for. Every row then contains information on the runtimes and model sizes. A detailed explanation of the columns can be found in the <code>README.md</code> of the data folder.</li> <li>PRISM model files with <code>.nm</code> or <code>.prism</code> extension, corresponding to the models used for the experiments.</li> <li>PRISM property files with <code>.props</code> extension, corresponding to the queries used for the experiments.</li> <li>A <code>README.md</code> with notes on the origins of the models.</li> </ul> <div> <h3>The <code>software</code> folder</h3> <a href="https://github.com/cxlvinchau/cav2024-experiments#the-software-folder"></a></div> <p>The <code>software</code> directory contains our implementation of the presented techniques, including computation of the certificates (aka certification), computation of witnessing schedulers and the computation of minimal witnessing subsystems. It consists of the following components:</p> <ul> <li><code>cpmc</code> contains the Python implementation of the techniques and consists of several submodules: <ul> <li><code>cpmc/core</code> implements classes for representing MDPs and other modeling components</li> <li><code>cpmc/mean_payoff</code> implements the techniques for working with multi-objective mean-payoff queries</li> <li><code>cpmc/reachability</code> implements the techniques for working with multi-objective reachability queries</li> <li><code>cpmc/prism</code> implements the translation of subsystems to PRISM code</li> <li><code>cpmc/test</code> contains unit tests that can be run by navigating into the folder and running <code>pytest .</code></li> </ul> </li> <li><code>experiments</code> contains scripts and utility files for running the experiments: <ul> <li><code>experiments/phil.py</code> Script for running the dining philosophers experiment</li> <li><code>experiments/csn.py</code> Script for running the csn mean-payoff experiment</li> <li><code>experiments/csn_reachability.py</code> Script for running the csn reachability experiment</li> <li><code>experiments/sensors.py</code> Script for running the sensors experiment</li> <li><code>experiments/consensus.py</code> Script for running the consensus (coin) experiment</li> <li><code>experiments/firewire.py</code> Script for running the firewire experiment</li> <li><code>experiments/main.py</code> Command line interface for runnign the experiments</li> </ul> </li> </ul>
Analyses of a deactivation genetic variation in Ha-Ras proto oncogene identified in a patient wit premature aging and insulin resistance
GEO Series GSE49566. Homo sapiens. 9 samples. Type: Expression profiling by array.
Dataset related to the article "High sensitivity C-reactive protein and acute kidney injury in patients wit acute myocardial infarction: a prospective observational study"
<p>This record contains raw data related to the article "High sensitivity C-reactive protein and acute kidney injury in patients wit acute myocardial infarction: a prospective observational study"</p> <p><strong>Abstract:</strong> Background. Accumulating evidence suggests that inflammation plays a key role in acute<br> kidney injury (AKI) pathogenesis. We explored the relationship between high-sensitivity C-reactive<br> protein (hs-CRP) and AKI in acute myocardial infarction (AMI). Methods. We prospectively included<br> 2,063 AMI patients in whom hs-CRP was measured at admission. AKI incidence and a clinical<br> composite of in-hospital death, cardiogenic shock, and acute pulmonary edema were the study<br> endpoints. Results. Two-hundred-thirty-four (11%) patients developed AKI. hs-CRP levels were<br> higher in AKI patients (45 87 vs. 16 41 mg/L; p < 0.0001). The incidence and severity of AKI, as well<br> as the rate of the composite endpoint, increased in parallel with hs-CRP quartiles (p for trend <0.0001<br> for all comparisons). A significant correlation was found between hs-CRP and the maximal increase<br> of serum creatinine (R = 0.23; p < 0.0001). The AUC of hs-CRP for AKI prediction was 0.69 (p < 0.001).<br> At reclassification analysis, addition of hs-CRP allowed to properly reclassify 14% of patients when<br> added to creatinine and 8% of patients when added to a clinical model. Conclusions. In AMI,<br> admission hs-CRP is closely associated with AKI development and severity, and with in-hospital<br> outcomes. Future research should focus on whether prophylactic renal strategies in patients with<br> high hs-CRP might prevent AKI and improve outcome.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.